GlassScriptPhysician profile
David C Miller
NPI 1275510588
$3,622.40
in general payments reported to CMS, 2019-2025
17 companies · $429 in 2025
The $429 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $481 · 2020: $136 · 2021: $361 · 2022: $1,032 · 2023: $579 · 2024: $604 · 2025: $429.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,612.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,611.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,115.00 | 2021-2024 | Cd Horizon Spinal System, Osteocool Rf Ablation System, Intellis Adaptivestim |
| Zimmer Biomet Holdings, INC. | $784.40 | 2020-2024 | Persona, Rosa |
| Providence Medical Technology, INC. | $621.27 | 2022-2025 | |
| Stryker Corporation | $375.47 | 2019 | |
| Abbott Laboratories | $183.73 | 2019-2025 | Proclaim, Eterna |
| Si-Bone, INC. | $151.42 | 2023-2025 | |
| Think Surgical, INC. | $93.60 | 2024 | |
| Globus Medical, INC. | $42.71 | 2023-2025 | Senza, Excelsiusgps Robotic Navigation System |
| Sanofi-Aventis U.S. LLC | $36.91 | 2019-2023 | |
| Avanos Medical | $33.84 | 2019-2023 | Trivisc Sodium Hyaluronate |
| Pacira Pharmaceuticals Incorporated | $30.90 | 2020-2023 | Zilretta, Iovera, Exparel |
| Pacira Therapeutics, INC. | $29.94 | 2020 | |
| Baxter Healthcare | $28.18 | 2022-2023 | Floseal |
| Intrinsic Therapeutics | $27.51 | 2025 | Barricaid Acd (Annular Closure Device) |
| Surgalign Spine Technologies, INC. | $25.95 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $23.37 | 2019 | |
| Ferring Pharmaceuticals INC. | $18.20 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Miller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.